Publications by authors named "Ryuta Ohira"
Respirol Case Rep
March 2024
Article Synopsis
- - A 76-year-old man with lung cancer received atezolizumab, a PD-L1 inhibitor, but developed fatigue and was diagnosed with atezolizumab-induced sclerosing cholangitis shortly after treatment.
- - He was treated with steroids, leading to improvement in his symptoms and laboratory results, although he faced complications like liver abscesses later on.
- - The case highlights the rarity and potential severity of sclerosing cholangitis as a side effect of immune checkpoint inhibitors, underscoring the need for awareness regarding this condition in clinical practice.
